Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Resampling and Retesting

Posted on By

SOP for Resampling and Retesting

Procedures for Resampling and Retesting

1) Purpose

The purpose of this SOP is to provide clear guidelines for resampling and retesting materials or products when initial results are questionable or invalidated to ensure the accuracy and reliability of test results.

2) Scope

This SOP applies to all instances where initial test results for raw materials, in-process materials, or finished products are questionable or invalidated within the pharmaceutical manufacturing facility.

3) Responsibilities

The Quality Control (QC) department is responsible for implementing and following this SOP. All personnel involved in resampling and retesting must be adequately trained on this procedure.

See also  SOP for Change Control: Procedures for Managing Changes to Processes, Equipment, or Procedures

4) Procedure

  1. Initiation of Resampling and Retesting:
    1. Identify the need for resampling and retesting based on initial test results that are questionable or invalidated.
    2. Obtain approval from the QC manager or designated authority before proceeding.
  2. Resampling Process:
    1. Follow the same sampling procedure outlined in the initial sampling SOP to ensure consistency.
    2. Collect new samples from the same batch or lot of material or product.
    3. Label the new samples appropriately with details including batch number, date, and reason for resampling.
  3. Retesting Process:
    1. Transfer the resampled material to the laboratory under suitable conditions.
    2. Perform the same tests as were conducted initially, following the same methods and procedures.
    3. Document all retesting activities and compare results with
initial tests.
  • Review and Documentation:
    1. Review the results of the retesting to determine if they are consistent with initial findings.
    2. If discrepancies remain, investigate potential causes and document findings.
    3. Record all details of the resampling and retesting process in the appropriate logbooks and forms.
  • 5) Abbreviations, if any

    QC: Quality Control

    6) Documents, if any

    Initial Test Results, Resampling Forms, Retesting Logbooks, and Investigation Reports

    7) Reference, if any

    Relevant regulatory guidelines such as ICH Q7 and FDA Guidance for Industry

    8) SOP Version

    Version 1.0

    See also  SOP for Material Handling and Storage: Guidelines for the Proper Handling, Storage, and Labelling of Raw Materials and Intermediates
    Capsule Formulation Tags:Capsule Batch Record, Capsule Blending, Capsule Cleaning Validation, Capsule Coating, Capsule Deviation Investigation, Capsule Dosage Form, Capsule Encapsulation, Capsule Equipment Qualification, Capsule Filling, Capsule Formulation SOP, Capsule Inspection Procedure, Capsule Integrity, Capsule Manufacturing, Capsule Mixing, Capsule Polishing, Capsule Production, Capsule Quality Control, Capsule Sampling, Capsule Shell Inspection, Capsule Weight Check

    Post navigation

    Previous Post: SOP for Sampling and Testing
    Next Post: SOP for Sampling and Testing of Raw Materials in Ointment Formulation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version